1 |
Duarte, A., F. Boavida, F. Grosso, M. Correia, L. M. Lito, J. Melo Cristino, and M. J. Salgado. 2003. Outbreak of GES-1 -lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob. Agents Chemother. 47: 1481-1482
DOI
|
2 |
Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A -lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44: 2247-2253
DOI
|
3 |
Jeong, S. H., I. K. Bae, D. Kim, S. G. Hong, J. S. Song, J. H. Lee, and S. H. Lee. 2005. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum -lactamases in Korea. Antimicrob. Agents Chemother. 49: 4809-4810
DOI
ScienceOn
|
4 |
Paterson, D. L., W.-C. Ko, A. Von Gottberg, J. M. Casellas, L. Mulazimoglu, K. P. Klugman, R. A. Bonomo, L. B. Rice, J. G. McCormack, and V. L. Yu. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum -lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39: 2206-2212
DOI
ScienceOn
|
5 |
Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum -lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44: 622-632
DOI
|
6 |
Vourli, S., P. Giakkoupi, V. Miriagou, E. Tzelepi, A. C. Vatopoulos, and L. S. Tzouvelekis. 2004. Novel GES/IBC extended-spectrum -lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 234: 209-213
|
7 |
Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A -lactamase, GES-4, possessing a single G170S substitution in the -loop. Antimicrob. Agents Chemother. 48: 2905-2910
DOI
ScienceOn
|
8 |
Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ito, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A -lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48: 1960-1967
DOI
ScienceOn
|
9 |
Bradford, P. A. 2001. Extended-spectrum -lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951
DOI
ScienceOn
|
10 |
Lee, S. H., S. H. Jeong, J.-I. Wachino, T. Arakawa, L. Poirel, and P. Nordmann. 2005. Nomenclature of GES-type extended-spectrum -lactamases. Antimicrob. Agents Chemother. 49: 2148-2150
DOI
ScienceOn
|
11 |
Sanders, C. C. and W. E. Jr. Sanders. 1992. -Lactamase in Gram-negative bacteria: Global trends and clinical impact. Clin. Infect. Dis. 15: 824-839
DOI
ScienceOn
|
12 |
Lee, S. H., S. H. Jeong, and S.-S. Cha. 2005. Minimising antibiotic resistance. Lancet Infect. Dis. 5: 668-670
DOI
ScienceOn
|
13 |
Pasteran, F., D. Faccone, A. Petroni, M. Rapoport, M. Galas, M. Vazquez, and A. Procopio. 2005. Novel variant of the metallo- -lactamase family in a GES-1 extended-spectrum- -lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49: 474-475
DOI
ScienceOn
|
14 |
Poirel, L., L. Brinas, N. Fortineau, and P. Nordmann. 2005. Integron-encoded GES-type extended-spectrum -lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 3593-3597
DOI
ScienceOn
|
15 |
Lee, J. H. and S. H. Lee. 2006. Carbapenem resistance in Gram-negative pathogens: Emerging non-metallo-carbapenemases. Res. J. Microbiol. 1: 1-22
DOI
|
16 |
Jung, H. J., K. S. Choi, and D. G. Lee. 2005. Synergistic killing effect of synthetic peptide P20 and cefotaxime on methicillin-resistant nosocomial isolates of Staphylococcus aureus. J. Microbiol. Biotechnol. 15: 1039-1046
과학기술학회마을
|
17 |
Rhie, H. G., S. J. Lee, and H. S. Lee. 2004. Characterization of the plasmid-encoded arsenic salts resistance determinant from Klebsiella oxytoca D12. J. Microbiol. Biotechnol. 14: 593-598
|
18 |
Correia, M., F. Boavida, F. Grosso, M. J. Salgado, L. M. Lito, J. Melo Cristino, S. Mendo, and A. Duarte. 2003. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 47: 2838-2843
DOI
|
19 |
Kim, J. N., S. J. Lee, H. S. Lee, and H. G. Rhie. 2005. Inactivation of mutS leads to a multiple-drug resistance in Pseudomonas putida ATCC12633. J. Microbiol. Biotechnol. 15: 1214-1220
과학기술학회마을
|
20 |
Ryoo, N. H., E.-C. Kim, S. G. Hong, Y. J. Park, K. Lee, I. Kwon Bae, E. H. Song, and S. H. Jeong. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56: 698-702
DOI
ScienceOn
|
21 |
Mavroidi, A., E. Tzelepi, A. Tsakris, V. Miriagou, D. Sofianou, and L. S. Tzouvelekis. 2001. An integron-associated -lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum -lactamase IBC-1. J. Antimicrob. Chemother. 48: 627-630
DOI
ScienceOn
|
22 |
Pasteran, F., D. Faccone, K. Campos, M. Vasquez, M. Rapoport, A. Littvik, M. Tokumoto, and M. Galas. 2004. Dissemination of GES extended-spectrum -lactamase-producing Pseudomonas aeruginosa (PA) in Argentina. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 105. American Society for Microbiology, Washington, D.C
|
23 |
Hall, R., S. Partridge, P. A. Bradford, K. Bush, G. A. Jacoby, L. B. Rice, and L. S. Young. 2003. Unambiguous numbering of antibiotic resistance genes. Antimicrob. Agents Chemother. 47: 3998-3999
DOI
|
24 |
George, H. T., J. Bradley, J. E. Edwards Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs; an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42: 657-668
DOI
ScienceOn
|
25 |
Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A -lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45: 2598-2603
DOI
|
26 |
Castanheira, M., R. E. Mendes, T. R. Walsh, A. C. Gales, and R. N. Jones. 2004. Emergence of the extended-spectrum -lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: Report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 48: 2344-2345
DOI
ScienceOn
|
27 |
Weldhagen, G. F. 2004. Rapid detection and sequence-specific differentiation of extended-spectrum -lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay. Antimicrob. Agents Chemother. 48: 4059-4062
DOI
ScienceOn
|
28 |
Cho, B. G., C. H. Kim, B. K. Lee, and S. H. Cho. 2005. Comparison of antibiotic resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733
과학기술학회마을
|
29 |
Livermore, D. M. 1995. -Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584
|